T1	Participants 231 288	patients with moderate to severe congestive heart failure
T2	Participants 290 350	Seventeen patients on chronic digitalis and diuretic therapy
T3	Participants 702 730	flosequinan-treated patients
T4	Participants 1147 1201	patients with moderate to severe chronic heart failure
